INTERNATIONAL PATENT: MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT FILES APPLICATION FOR "CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST THE CHEMOKINE RECEPTOR CCR7"

GENEVA, June 23 -- MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (Robert-Rossle-Str. 1013125 Berlin) filed a patent application (PCT/EP2024/086312) for "CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST THE CHEMOKINE RECEPTOR CCR7" on Dec 13, 2024. With publication no. WO/2025/125610, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOPKEN, Uta Elisabeth (SuarezstraBe 4114057 Berlin), REHM, Armin (Suarezstr. 4114057 Berlin), MASSARO, Marialucia (Lindenhoek Weg 510409 Berlin), BUNSE, Mario (Riemannstr. ...